VIRACEPT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Nelfinavir Mesylate.
Product ID | 55289-477_7bbfc667-bfa8-08c2-e053-2a91aa0a8009 |
NDC | 55289-477 |
Product Type | Human Prescription Drug |
Proprietary Name | VIRACEPT |
Generic Name | Nelfinavir Mesylate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1997-03-14 |
Marketing Category | NDA / NDA |
Application Number | NDA020779 |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | NELFINAVIR MESYLATE |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2011-04-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020779 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-21 |
Marketing End Date | 2019-09-12 |
Ingredient | Strength |
---|---|
NELFINAVIR MESYLATE | 250 mg/1 |
SPL SET ID: | 91152af4-a9c8-4b14-acbb-e4b6f2be145a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
52959-289 | VIRACEPT | nelfinavir mesylate |
53808-0809 | Viracept | NELFINAVIR MESYLATE |
55289-477 | VIRACEPT | nelfinavir mesylate |
63010-010 | VIRACEPT | nelfinavir mesylate |
63010-027 | VIRACEPT | nelfinavir mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VIRACEPT 74683161 2007831 Live/Registered |
AGOURUN PHARMACEUTICALS, LLC 1995-06-01 |